Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hela Elkin"'
Autor:
Yoav Mazor, Yehuda Chowers, Edna Efrati, Amir Karban, Hela Elkin, Norberto Krivoy, Eduard Koifman
Publikováno v:
Current Drug Safety. 8:181-185
Purpose: Thiopurines are effective in attaining and maintaining remission in patients with inflammatory bowel diseases (IBD). The major drawback of these drugs are their serious adverse effects (SAE), highlighting the importance of preemptive identif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::735ff173f8c7d0d1da7ac7d4d1b6c552
https://doi.org/10.2174/15748863113089990033
https://doi.org/10.2174/15748863113089990033
Autor:
Eli Sprecher, Jacob M. Rowe, Edna Efrati, Hela Elkin, Ronit Elhasid, Lior Adler, Norberto Krivoy
Publikováno v:
Pediatric Blood & Cancer. 55:1172-1179
Background Busulfan (BU), often used in high dose for myeloablation before hematopoietic stem cell transplantation (HSCT), has been implicated in certain HSCT toxicities, including the occurrence of hepatic veno-occlusive disease (HVOD). In addition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a32b297094f845dbaf1fd0a49821e16
https://doi.org/10.1002/pbc.22739
https://doi.org/10.1002/pbc.22739
Autor:
Yoav, Mazor, Eduard, Koifman, Hela, Elkin, Yehuda, Chowers, Norberto, Krivoy, Amir, Karban, Edna, Efrati
Publikováno v:
Current drug safety. 8(3)
Thiopurines are effective in attaining and maintaining remission in patients with inflammatory bowel diseases (IBD). The major drawback of these drugs are their serious adverse effects (SAE), highlighting the importance of preemptive identification o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9bf75bb0787d5c93364d08a694b54858
https://pubmed.ncbi.nlm.nih.gov/23845145
https://pubmed.ncbi.nlm.nih.gov/23845145
Publikováno v:
Current drug safety. 7(3)
High dose busulfan (BU) has become a mainstay in conditioning regimens for hematopoietic stem cell transplantation (HSCT), despite its unpredictable response, narrow therapeutic index and severe toxicity. The present study provides an integration of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f64f70d1b8027eaed833a98cd42b7ba0
https://pubmed.ncbi.nlm.nih.gov/22950985
https://pubmed.ncbi.nlm.nih.gov/22950985
Publikováno v:
Cancer biomarkers : section A of Disease markers. 8(2)
Introduction: KRAS mutations in colon carcinomas are associated with lack of response to anti-EGFR monoclonal antibody treatment. Therefore, patients must undergo genetic testing to be eligible for treatment. Several methods for KRAS mutation analysi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a92d4b5e2bf80c203da8f2f1afa1f54
https://pubmed.ncbi.nlm.nih.gov/21896996
https://pubmed.ncbi.nlm.nih.gov/21896996
Autor:
Dov Hershkovitz, Edna Efrati, Hela Elkin, Liora Farber, Yehudit Peerless, Edmond Sabo, Ofer Ben-Izhak
Publikováno v:
Virchows Archiv : an international journal of pathology. 459(5)
KRAS mutation status has a significant role determining anti-epidermal growth factor receptor (anti-EGFR) treatment response in colon carcinoma patients. Malignant transformation is a dynamic process and therefore, it is conceivable that, at a certai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c417ec2ced68de4bb1b66f89fef1649d
https://pubmed.ncbi.nlm.nih.gov/22016105
https://pubmed.ncbi.nlm.nih.gov/22016105
Autor:
Lior Adler, Yehuda Chowers, Edna Efrati, Norberto Krivoy, Amir Karban, Hela Elkin, Rami Eliakim
Publikováno v:
Digestive diseases and sciences. 56(7)
The involvement of oxidant/antioxidant imbalance in the development of inflammatory bowel disease (IBD) is well documented. Two members of the glutathione S-transferase (GST) family of enzymes, GSTM1 and GSTT1, known to take part in cellular protecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d39fbd63296731512f8080ce8a056c5b
https://pubmed.ncbi.nlm.nih.gov/21243434
https://pubmed.ncbi.nlm.nih.gov/21243434
Autor:
Ronit, Elhasid, Norberto, Krivoy, Jacob M, Rowe, Eli, Sprecher, Lior, Adler, Hela, Elkin, Edna, Efrati
Publikováno v:
Pediatric bloodcancer. 55(6)
Busulfan (BU), often used in high dose for myeloablation before hematopoietic stem cell transplantation (HSCT), has been implicated in certain HSCT toxicities, including the occurrence of hepatic veno-occlusive disease (HVOD). In addition to weight a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a8758a01b3a316696c25dd73c1059492
https://pubmed.ncbi.nlm.nih.gov/20672371
https://pubmed.ncbi.nlm.nih.gov/20672371
Publikováno v:
Current drug safety. 5(3)
Purpose: This study was designed to delineate the relative frequency of CYP2C9 and VKORC1 polymorphisms known to affect warfarin response in the highly heterogeneous Israeli population. Methods: Frequencies of CYP2C9 allelic variants CYP2C9*2, CYP2C9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8acf6cc87afa35136caa00c757d28b8e
https://pubmed.ncbi.nlm.nih.gov/20210733
https://pubmed.ncbi.nlm.nih.gov/20210733